Activity of cefepime, ceftazidime, and ceftizoxime against mutants of Enterobacteriaceae and Pseudomonas aeruginosa derepressed for class I beta-lactamase.
Knapp
C C
CC
Cleveland Clinic Foundation, Ohio 44195-5140.
Washington
J A
JA
D000077723:Cefepime; D002442:Ceftazidime / Q000494:pharmacology; D015296:Ceftizoxime / Q000494:pharmacology; D002511:Cephalosporins / Q000494:pharmacology*; D004755:Enterobacteriaceae / Q000187:drug effects* / Q000235:genetics; D004794:Enzyme Repression / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D010405:Penicillinase / Q000235:genetics*; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000235:genetics
D002511:Cephalosporins; D000077723:Cefepime; D002442:Ceftazidime; D015296:Ceftizoxime; D010405:Penicillinase